squalane has been researched along with Plasmodium falciparum Malaria in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bryan, JP; Church, P; Davis, J; Edelman, R; Gordon, D; Gross, M; Hoffman, SL; Schneider, I; Sedegah, M; Silverman, C | 1 |
1 trial(s) available for squalane and Plasmodium falciparum Malaria
Article | Year |
---|---|
Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvant.
Topics: Adjuvants, Immunologic; Adult; Amino Acid Sequence; Animals; Antibodies, Protozoan; Cell Wall; Double-Blind Method; Humans; Lipid A; Malaria Vaccines; Malaria, Falciparum; Middle Aged; Military Personnel; Molecular Sequence Data; Mycobacterium phlei; Parasitemia; Plasmodium falciparum; Protozoan Proteins; Safety; Squalene; United States; Vaccines, Synthetic | 1994 |